Papers
1
Total Citations
20
H-Index
1
About
Mathew Chetta is a pioneering surgeon-researcher whose work centers on advancing oncologic safety and surgical precision in breast cancer treatment, particularly through minimally invasive techniques. His major contributions lie in evaluating the efficacy of robot-assisted nipple sparing mastectomy (RNSM), a procedure that preserves the nipple-areola complex while aiming for complete cancer removal. In his highly cited 2020 study, Chetta introduced a critical surrogate marker—histologically detected residual breast tissue (RBT)—to assess the oncologic soundness of RNSM. By systematically analyzing RBT presence, he provided foundational evidence that helps refine surgical protocols, balancing cosmetic outcomes with cancer control. This work has garnered 20 citations, reflecting its influence on clinical decision-making and future research directions. Chetta’s research directly addresses a key concern in breast surgery: ensuring that innovative, patient-centered approaches do not compromise long-term safety. His findings are essential reading for surgeons and oncologists seeking to optimize mastectomy techniques, and they underscore his role in shaping evidence-based practices that improve both survival and quality of life for patients.
Research Focus
Key Achievements
Top Papers
- 1Residual breast tissue after robot-assisted nipple sparing mastectomy20 citations · 2020